Los Angeles Capital Management & Equity Research Inc. Grows Stake in CME Group Inc. (CME)

Los Angeles Capital Management & Equity Research Inc. lifted its position in shares of CME Group Inc. (NASDAQ:CME) by 1,095.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 168,712 shares of the financial services provider’s stock after purchasing an additional 154,596 shares during the period. Los Angeles Capital Management & Equity Research Inc.’s holdings in CME Group were worth $22,891,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Honkamp Krueger Financial Services Inc. lifted its stake in shares of CME Group by 0.4% in the second quarter. Honkamp Krueger Financial Services Inc. now owns 2,937 shares of the financial services provider’s stock worth $368,000 after acquiring an additional 13 shares during the period. Hudock Capital Group LLC lifted its stake in shares of CME Group by 0.5% in the second quarter. Hudock Capital Group LLC now owns 3,890 shares of the financial services provider’s stock worth $487,000 after acquiring an additional 20 shares during the period. Whittier Trust Co. lifted its stake in shares of CME Group by 2.6% in the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock worth $133,000 after acquiring an additional 27 shares during the period. Ropes Wealth Advisors LLC lifted its stake in shares of CME Group by 0.4% in the second quarter. Ropes Wealth Advisors LLC now owns 10,801 shares of the financial services provider’s stock worth $1,353,000 after acquiring an additional 38 shares during the period. Finally, CAPROCK Group Inc. lifted its stake in shares of CME Group by 0.9% in the second quarter. CAPROCK Group Inc. now owns 5,787 shares of the financial services provider’s stock worth $725,000 after acquiring an additional 50 shares during the period. Institutional investors own 82.63% of the company’s stock.

CME Group Inc. (NASDAQ:CME) opened at $139.67 on Thursday. CME Group Inc. has a 12 month low of $111.19 and a 12 month high of $141.44. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $47,543.92, a P/E ratio of 29.33, a price-to-earnings-growth ratio of 2.88 and a beta of 0.71.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The firm had revenue of $890.80 million during the quarter, compared to the consensus estimate of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The company’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.05 earnings per share. equities research analysts anticipate that CME Group Inc. will post 4.78 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Friday, December 8th will be issued a dividend of $0.66 per share. The ex-dividend date is Thursday, December 7th. This represents a $2.64 annualized dividend and a dividend yield of 1.89%. CME Group’s dividend payout ratio is 59.86%.

A number of equities analysts recently commented on CME shares. BidaskClub lowered CME Group from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Royal Bank Of Canada set a $135.00 price objective on CME Group and gave the stock a “buy” rating in a research note on Tuesday, August 1st. Keefe, Bruyette & Woods reaffirmed a “hold” rating and issued a $127.00 price objective on shares of CME Group in a research note on Friday, August 18th. UBS AG reaffirmed a “buy” rating and issued a $135.00 price objective (up from $134.00) on shares of CME Group in a research note on Wednesday, September 6th. Finally, Barclays PLC started coverage on CME Group in a research note on Friday, September 8th. They issued an “overweight” rating and a $139.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and seven have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $141.75.

ILLEGAL ACTIVITY NOTICE: This story was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this story on another website, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this story can be read at https://ledgergazette.com/2017/11/16/los-angeles-capital-management-equity-research-inc-grows-stake-in-cme-group-inc-cme.html.

In other news, CFO John W. Pietrowicz sold 5,175 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $139.70, for a total transaction of $722,947.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Daniel R. Glickman sold 850 shares of the business’s stock in a transaction that occurred on Monday, August 28th. The shares were sold at an average price of $126.65, for a total value of $107,652.50. Following the sale, the director now owns 13,799 shares of the company’s stock, valued at approximately $1,747,643.35. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 11,339 shares of company stock valued at $1,548,086. Corporate insiders own 0.57% of the company’s stock.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply